OVERVIEW

40th pharmacovigilance UK & EU 2026 is organized by Virtue Insight and will be held from Mar 11 - 12, 2026 at Sheraton Skyline Hotel London Heathrow, London, England, United Kingdom.

Description:
This event will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Take a chance and make it count by attending our event to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level. It gives me great pleasure in welcoming all of you to the Virtue Insight’s 40th Pharmacovigilance UK & EU 2026. I wish and pray that all our efforts will be beneficial to our industries and to our all at large.

Key Themes Discussed This Year:

  • CHALLENGES / OPPORTUNITIES
  • PATIENT SAFETY
  • RMP/ REMS
  • SAFETY & SIGNAL DETECTION
  • AUTOMATION IN PV
  • REGULATORY
  • MEDICAL DEVICES
  • IMPACT OF TECHNOLOGY AI, ML
  • AUDITS & INSPECTION
  • RWE / RWD
  • OUTSOURCING
  • MARKET TRENDS - CRITIQUES & WAYS FORWARD

Key Speakers:
KARSTEN LOLLIKE, Scientific VP, Deputy QPPV, Global Patient Safety, Novo Nordisk

STEPHANIE MILLICAN, Deputy Director BRE II, MHRA

MICHAEL BEAN, Senior Director, Regulatory Compliance, Johnson & Johnson

JEAN-MARC HAUSLER, Global Head of International Patient Safety, F. Hoffmann-La Roche

CHETAN SHATAPATHY, Executive Director & Head, ADC Group, Patient Safety Oncology, AstraZeneca

LEONA HOUGHTON, Vice President, Global Safety (Ex-US), Mundipharma

MIRCEA CIUCA, Independent PV Consultant / International PV Expert (Former Global Head Medical Safety, Organon)

MIJAL CHAVDA, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin

REMCO M. DIAB, Sr. Dir. Lead Global Safety Officer Immunology & Inflammation, Sanofi

VALENTINA MANCINI, Senior Director Pharmacovigilance, QPPV, Shionogi Europe

JUDY BARRETTO, Senior Director, Virology TA, Patient Safety, Gilead Sciences

CHRISTIAN MUHL, Senior Director Compliance, GSK

MARIJA SIMIC, Director Medical Safety Team Lead, Global Patient Safety, Sandoz

PAV RISHIRAJ, Director, Head of Pharmacovigilance, Ipsen

CALVIN JOHNSON, Executive Director & Head of International Patient Safety, Bristol-Myers Squibb

JASON BRYANT, SVP, Product Management, AI, ArisGlobal

LEA GALOVIC, Associate Director¸ Risk Management, Global Patient Safety & PV, Teva

YVONNE NANCIU, Country Head Pharmacovigilance Deputy EU QPPV, Bayer

PUNAM KUMARI, Founder & MD, Biovance Solutions

TEA BABIC, Director, PV Audits & Inspections, Teva

TERESA SARAGOCA, Director, Regulatory Affairs & Technical Manager, ITALFARMACO

SMRUTTI KOTHARI, Associate Director, Global Patient Safety. Quality & Compliance, Regeneron Pharmaceuticals

SABINE POLTERMANN, Head of Country Patient Safety Switzerland, Bristol-Myers Squibb

JOHN SOLOMON, Former Head of Pharmacovigilance - UK & Ireland, Sanofi

BEGUM BENLI PEKER, Head of Patient Safety EU Hub, Bristol-Myers Squibb

SIMON ASHWORTH, Head of Pharmacovigilance & Medical Safety, MENARINI Group

SUMIT MUNJAL, Global Head of Medical Safety, Otsuka Pharmaceuticals

RISHI CHOPRA, Head of International PV & Global PV Operations | Dep. UK QPPV, CSL Behring

PHILLIP EICHORN, Global Head of Drug Safety, Amryt Pharma

GALINA CORDERO, Head of Pharmacovigilance Dept, QPPV, JSC Farmak

WOLF HENNING GEBHARDT, R&D Scientist Advanced Analytics, Abbott

ABIDALI FAZAL, Safety Science Director, Roche

MARJAN DZEPAROSKI, Head of Regulatory Affairs, Drug Safety & Intelectual Property, Bionika Pharmaceuticals

RUDI SCHEERLINCK, Safety Strategy Lead – Oncology, Healthcare Business of Merck

MICHAEL VON FORSTNER, Chief Scientific Officer, MedGenie

RAGHDA MOHAMED, Patient Safety Cluster Lead - Middle East & Turkey / Global patient Safety Evaluation, Takeda Pharmaceuticals

LEONARDO PEREIRA, Clinical Safety Director, Roche

REEM YASIN, Quality Assurance & PV Manager, Hawkary Pharmaceuticals

ARUN RAVINDRAN, Benefit Risk Lead (Late phase Clinical, Development Safety), UCB

ZINA SADEQ, Director, Regional PV & Alliance Management, UK QPPV, Amicus Therapeutics

CINTHYA GALICIA QUINTANAR, Senior Manager, Country Safety Lead, Pfizer

SANJEEV SRIVASTAV, Signal Management Lead, BioNTech

KEY DATES

Event Start Date
11 Mar, 2026
Event Start Date
Event End Date
12 Mar, 2026
Event End Date

TARGET AUDIENCE

Bio-Pharma CompaniesDrug-delivery developersDrug developersFormulation and Drug DeliveryMedical AffairsDrug Research & DevelopmentSafety & Risk management

SPECIALITIES

Pharmacy and Medicine Pharmacology

SUGGESTED HOTELS

CONFERENCE VENUE

LocationSheraton Skyline Hotel London Heathrow
Heathrow Airport, Bath Rd, Hayes

RELATED CONFERENCES & LIVE WEBINARS

Jul 23 - 24, 2026 | Vienna, Wien, AT

Research and Clinical Research
More actions
AT€350